Eagle Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 2.58, indicating more challenging environment then in the first quarter 2023, but still, it is a far cry from any concerns. Eagle Pharmaceuticals Inc 's Accounts Receivable average collection period in the Jun 30 2023 quarter, has increased to 141 days, from 126 days, in the Mar 31 2023 quarter.

If we take a look into Healthcare sector 182 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2023 from 1750 to 1754.

What is Receivable Turnover Ratio?
What is Eagle Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

EGRX Receivables Turnover Ratio	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter
Y / Y Receivable Change	34.01 %	-12.15 %	76.04 %	113.81 %	63.16 %
Y / Y Revenue Change	-12.8 %	-42.78 %	43.43 %	65.36 %	54.05 %
Receivable Turnover Ratio (TTM)	2.58	2.89	3.28	3.36	3.59
EGRX's Total Ranking	# 1754	# 1750	# 1743	# 704	# 3459
Accounts Receivable average collection period days	142	127	111	109	102
Seq. Receivable Change	0.16 %	58.69 %	-25.27 %	12.82 %	-34.34 %
Seq. Revenue Change	-2.5 %	9.24 %	-7.89 %	-11.11 %	-36.02 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 40
Healthcare Sector	# 183
Overall Market	# 1754

Receivable Turnover Ratio Statistics
High	Average	Low
1.29	0.82	0.48
(Mar 31 2017)		(March 31, 2016)

EGRX Company Profile • Back to EGRX Efficiency Comparisons • Compare EGRX Receivables Turnover Ratio to its Competitors

Financial Statements
Eagle Pharmaceuticals Inc 's Accounts Receivable	$ 115 Millions	Visit EGRX's Balance sheet
Eagle Pharmaceuticals Inc 's Sales TTM	$ 258 Millions	Visit EGRX's Income Statement
Sources of EGRX's Revenues		Visit EGRX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
EGRX's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
EGRX's Growth Rates	EGRX's Roa	EGRX's Inventory Turnover Ratio	EGRX's Dividend Comparisons
EGRX's Profitability Ratios	EGRX's Roi	EGRX's Asset Turnover Ratio	EGRX's Dividend Growth
EGRX's Valuation Ratios	EGRX's Roe	EGRX's Financial Strength Ratios	EGRX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2023	Receivable at quarter ending Jun 30 2023
Biocryst Pharmaceuticals Inc	6.15	$ 306.641 Millions	$ 49.879 Millions
Pacific Biosciences Of California Inc	6.14	$ 146.110 Millions	$ 23.791 Millions
Neuropace Inc	6.14	$ 54.390 Millions	$ 8.857 Millions
Aravive Inc	6.13	$ 9.195 Millions	$ 1.500 Millions
Community Health Systems Inc	6.12	$ 12,389.000 Millions	$ 2,023.750 Millions
The Cooper Companies Inc	6.08	$ 3,513.900 Millions	$ 577.550 Millions
Maravai Lifesciences Holdings Inc	6.08	$ 543.915 Millions	$ 89.488 Millions
Carlisle Companies Incorporated	6.07	$ 5,151.200 Millions	$ 849.000 Millions
Mettler toledo International Inc	6.06	$ 3,954.386 Millions	$ 652.193 Millions
Bellicum Pharmaceuticals Inc	6.06	$ 1.527 Millions	$ 0.252 Millions
Dentsply Sirona Inc	6.06	$ 3,936.000 Millions	$ 649.750 Millions
Jazz Pharmaceuticals Plc	6.05	$ 3,762.904 Millions	$ 621.750 Millions
Biogen Inc	6.05	$ 9,971.500 Millions	$ 1,648.525 Millions
Pacific Health Care Organization Inc	6.04	$ 5.529 Millions	$ 0.915 Millions
Integra Lifesciences Holdings Corp	6.03	$ 1,545.326 Millions	$ 256.098 Millions
Livanova Plc	6.03	$ 1,084.779 Millions	$ 179.850 Millions
Hologic Inc	6.00	$ 4,038.100 Millions	$ 673.050 Millions
Bruker Corporation	5.98	$ 2,714.100 Millions	$ 454.125 Millions
Surgery Partners Inc	5.98	$ 2,661.500 Millions	$ 445.350 Millions
Opko Health Inc	5.96	$ 868.079 Millions	$ 145.742 Millions
Steris Plc	5.95	$ 5,085.890 Millions	$ 854.736 Millions
Champions Oncology Inc	5.95	$ 52.686 Millions	$ 8.855 Millions
Sutro Biopharma Inc	5.95	$ 56.865 Millions	$ 9.559 Millions
Sanuwave Health Inc	5.93	$ 18.115 Millions	$ 3.055 Millions
Cytomx Therapeutics Inc	5.93	$ 60.317 Millions	$ 10.173 Millions
Privia Health Group Inc	5.93	$ 1,506.950 Millions	$ 254.168 Millions
Msa Safety Inc	5.92	$ 1,670.841 Millions	$ 282.059 Millions
Stryker Corp	5.92	$ 19,455.000 Millions	$ 3,286.000 Millions
Retractable Technologies Inc	5.92	$ 53.662 Millions	$ 9.069 Millions
Nevro Corp	5.92	$ 419.446 Millions	$ 70.907 Millions

Date modified: 2026-09-08T15:11:01+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.